Market Closed -
Nyse
04:00:02 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
114.9
USD
|
-2.74%
|
|
-6.24%
|
-20.45%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,745
|
15,705
|
27,346
|
25,406
|
16,955
|
13,509
|
-
|
-
|
Enterprise Value (EV)
1 |
10,182
|
18,530
|
29,301
|
27,124
|
20,232
|
17,695
|
17,682
|
18,603
|
P/E ratio
|
14.5
x
|
41.9
x
|
221
x
|
9.49
x
|
10.8
x
|
40.7
x
|
9.17
x
|
9.52
x
|
Yield
|
2.01%
|
1.04%
|
0.67%
|
0.73%
|
-
|
1.38%
|
1.43%
|
1.47%
|
Capitalization / Revenue
|
2.16
x
|
5.02
x
|
8.22
x
|
3.47
x
|
1.76
x
|
2.29
x
|
1.86
x
|
1.6
x
|
EV / Revenue
|
2.84
x
|
5.92
x
|
8.8
x
|
3.71
x
|
2.1
x
|
3
x
|
2.43
x
|
2.21
x
|
EV / EBITDA
|
9.82
x
|
22.6
x
|
33.6
x
|
7.8
x
|
6
x
|
13.5
x
|
9.42
x
|
8.27
x
|
EV / FCF
|
-76.9
x
|
-359
x
|
-48.1
x
|
42
x
|
-24.6
x
|
-29.9
x
|
-127
x
|
46.3
x
|
FCF Yield
|
-1.3%
|
-0.28%
|
-2.08%
|
2.38%
|
-4.07%
|
-3.35%
|
-0.79%
|
2.16%
|
Price to Book
|
1.97
x
|
3.69
x
|
4.86
x
|
3.2
x
|
1.8
x
|
1.28
x
|
1.25
x
|
1.19
x
|
Nbr of stocks (in thousands)
|
106,033
|
106,457
|
116,976
|
117,153
|
117,353
|
117,527
|
-
|
-
|
Reference price
2 |
73.04
|
147.5
|
233.8
|
216.9
|
144.5
|
114.9
|
114.9
|
114.9
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,589
|
3,129
|
3,328
|
7,320
|
9,617
|
5,895
|
7,277
|
8,423
|
EBITDA
1 |
1,037
|
818.7
|
871
|
3,476
|
3,370
|
1,312
|
1,878
|
2,249
|
EBIT
1 |
823.3
|
586.8
|
617
|
3,175
|
2,940
|
742.4
|
1,313
|
1,537
|
Operating Margin
|
22.94%
|
18.75%
|
18.54%
|
43.37%
|
30.57%
|
12.59%
|
18.04%
|
18.25%
|
Earnings before Tax (EBT)
1 |
563
|
373.5
|
133.6
|
2,433
|
246.7
|
-437.9
|
1,283
|
1,931
|
Net income
1 |
533.2
|
375.8
|
123.7
|
2,690
|
1,573
|
355.2
|
1,492
|
2,909
|
Net margin
|
14.86%
|
12.01%
|
3.72%
|
36.75%
|
16.36%
|
6.02%
|
20.49%
|
34.54%
|
EPS
2 |
5.020
|
3.520
|
1.060
|
22.84
|
13.36
|
2.824
|
12.54
|
12.07
|
Free Cash Flow
1 |
-132.4
|
-51.56
|
-609.4
|
646.2
|
-824
|
-592.2
|
-138.9
|
401.7
|
FCF margin
|
-3.69%
|
-1.65%
|
-18.31%
|
8.83%
|
-8.57%
|
-10.05%
|
-1.91%
|
4.77%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
18.59%
|
-
|
-
|
-
|
17.86%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
24.02%
|
-
|
-
|
-
|
13.81%
|
Dividend per Share
2 |
1.470
|
1.540
|
1.560
|
1.580
|
-
|
1.588
|
1.642
|
1.693
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
894.2
|
1,128
|
1,480
|
2,092
|
2,621
|
2,580
|
2,370
|
2,311
|
2,356
|
1,361
|
1,378
|
1,521
|
1,686
|
1,546
|
1,634
|
EBITDA
1 |
228.7
|
431.9
|
610.2
|
1,190
|
1,244
|
1,596
|
1,032
|
453.3
|
289.1
|
291.2
|
291.5
|
332
|
388.7
|
406.6
|
447.2
|
EBIT
1 |
160.5
|
365.4
|
539.2
|
1,112
|
1,158
|
1,508
|
939.2
|
347.8
|
145
|
167.5
|
177
|
231.2
|
265.4
|
204.6
|
239.2
|
Operating Margin
|
17.95%
|
32.4%
|
36.44%
|
53.17%
|
44.19%
|
58.46%
|
39.62%
|
15.05%
|
6.15%
|
12.31%
|
12.85%
|
15.2%
|
15.74%
|
13.23%
|
14.63%
|
Earnings before Tax (EBT)
1 |
-8.062
|
299.6
|
401.5
|
869.3
|
863.1
|
1,157
|
168.4
|
-158.2
|
-921
|
-167.6
|
-48.1
|
-80.1
|
-26.05
|
-
|
-
|
Net income
1 |
-3.824
|
253.4
|
406.8
|
897.2
|
1,132
|
1,239
|
650
|
302.5
|
-617.7
|
-9.136
|
86.3
|
94.16
|
126.8
|
160
|
186
|
Net margin
|
-0.43%
|
22.47%
|
27.49%
|
42.89%
|
43.21%
|
48%
|
27.43%
|
13.09%
|
-26.22%
|
-0.67%
|
6.26%
|
6.19%
|
7.52%
|
10.35%
|
11.38%
|
EPS
2 |
-0.0300
|
2.150
|
3.460
|
7.610
|
9.600
|
10.51
|
5.520
|
2.570
|
-5.260
|
-0.0800
|
0.6250
|
0.6750
|
0.9450
|
1.130
|
1.310
|
Dividend per Share
2 |
0.3900
|
0.3950
|
0.3950
|
0.3950
|
0.3950
|
0.4000
|
0.4000
|
0.4000
|
-
|
-
|
0.3867
|
0.3867
|
0.3867
|
0.3900
|
0.4000
|
Announcement Date
|
2/16/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/15/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/14/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,437
|
2,825
|
1,955
|
1,718
|
3,277
|
4,186
|
4,173
|
5,095
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.351
x
|
3.451
x
|
2.245
x
|
0.4943
x
|
0.9723
x
|
3.19
x
|
2.222
x
|
2.265
x
|
Free Cash Flow
1 |
-132
|
-51.6
|
-609
|
646
|
-824
|
-592
|
-139
|
402
|
ROE (net income / shareholders' equity)
|
17.1%
|
9.16%
|
8.31%
|
19%
|
30.1%
|
3.45%
|
7.92%
|
6.88%
|
ROA (Net income/ Total Assets)
|
7.37%
|
3.7%
|
4.39%
|
19.6%
|
15.5%
|
2.38%
|
5.98%
|
8.85%
|
Assets
1 |
7,237
|
10,156
|
2,817
|
13,745
|
10,128
|
14,943
|
24,958
|
32,881
|
Book Value Per Share
2 |
37.10
|
39.90
|
48.10
|
67.80
|
80.20
|
89.70
|
92.10
|
96.20
|
Cash Flow per Share
2 |
6.770
|
7.480
|
2.970
|
16.20
|
11.30
|
13.00
|
11.10
|
17.50
|
Capex
1 |
852
|
850
|
954
|
1,262
|
2,149
|
1,707
|
1,612
|
1,753
|
Capex / Sales
|
23.73%
|
27.18%
|
28.66%
|
17.24%
|
22.35%
|
28.96%
|
22.16%
|
20.81%
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
114.9
USD Average target price
153.4
USD Spread / Average Target +33.50% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.45% | 13.51B | | +20.59% | 68.31B | | -1.02% | 48.49B | | +30.26% | 28.29B | | +7.56% | 19.12B | | +10.55% | 16.64B | | -5.73% | 16B | | -21.45% | 15.84B | | -24.56% | 12.98B | | +16.59% | 11.03B |
Other Specialty Chemicals
|